| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6100419 | Journal of Crohn's and Colitis | 2011 | 4 Pages |
Abstract
Inflammatory Bowel Disease (IBD) is thought to be the result of an overly aggressive immune response to ubiquitous antigens. Immuno -modulation and -suppression is therefore currently the treatment of choice. It was long anticipated that the course of pre-existing IBD should improve after orthotopic liver transplantation (OLT) due to increased immunosuppression. We report the case of a patient who developed acute fulminant colitis despite triple immunosuppression and mesalazine and review the relevant literature.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Antony Pan, Martin Schlup, Ralf Lubcke, Michael Schultz,